Atea Pharmaceuticals, Inc. (AVIR) stock
AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.99+0.03 (+0.76%)
Close on Nov 18, 2026Market cap $320.02MP/E –Yield –
Atea Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Atea Pharmaceuticals's price to sales ratio was 1.4× on Apr 29, 2022.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Apr 29, 2022 | 1.4× | – |
See a number that looks wrong?